pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

9,574 catalysts · 3,126 8k filing · 2,046 grant · 1,007 approval · 1,000 device adverse event · 732 device 510k · 583 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-21×clear all
type
  • 8k filing3,126
  • grant2,046
  • approval1,007
  • device adverse event1,000
  • device 510k732
  • earnings583
device pma
539
  • device recall255
  • recall204
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Jan 26, 2026

    50
    ›Jan 29, 2026device 510k195d agoHiossen, Inc. — EK MULTI ANGLED 30 ABUTMENT (510k cleared)

    Product code: NHA. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 29, 2026device 510k195d agoMedtox Diagnostics, Inc. — Labcorp Fentanyl Urine Visual Test (510k cleared)Co-Diagnostics, Inc.

    Product code: DJG. Advisory committee: Clinical Toxicology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 29, 2026device 510k195d agoFresenius Medical Care Renal Therapies Group, LLC — NaturaLyte® Dry Bicarbonate Concentrate (08-4112-2) (510k cleared)Fresenius Medical Care AG

    Product code: KPO. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 29, 2026device 510k195d agoConmed Corporation — Y-Knotless™ Flex Anchors (510k cleared)CONMED Corp

    Product code: MBI. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Jan 29, 2026device 510k195d agoJiangsu Jumao X-Care Medical Equipment Co., , Ltd. — Manual Wheelchair (W50) (510k cleared)

    Product code: IOR. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 29, 2026device pma195d agoQ-Med AB — Restylane®-L 1 mL; Restylane® Lyft™ with Lidocaine 1 mL; Restylane® Eyelight™ 0.5 mL (PMA supplement)Sustained Therapeutics Inc

    Supplement type: Normal 180 Day Track. Product code: LMH. Advisory committee: SU. Decision: APPR

    full page →fda device pma ↗
    ›Jan 29, 2026device pma195d agoVascutek, Ltd. — Thoraflex™ Hybrid (PMA supplement)

    Supplement type: Special (Immediate Track). Product code: QSK. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Jan 29, 2026device pma195d agoAutoGenomics, Inc. — AvertD™ and AvertD™ Buccal Sample Collection Kit (PMA supplement)NEOGENOMICS INC

    Supplement type: Normal 180 Day Track No User Fee. Product code: QZH. Advisory committee: TX. Decision: APPR

    full page →fda device pma ↗
    ›Jan 29, 2026device pma195d agoZoll Manufacturing Corporation — LifeVest® Wearable Defibrillator (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MVK. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Jan 29, 2026device pma195d agoHighridge Medical, LLC — activL Artificial Disc (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: MJO. Advisory committee: OR. Decision: APPR

    full page →fda device pma ↗
    ›Jan 29, 2026device recall195d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Single use Biopsy Valve. Model/Catalog Number: MAJ-210. 20 units per box. The MAJ-210 has been designed to be attached to the instrument channel port of compatible endoscopes to prevent reflux of body fluids. — Reason: Potential for rubber fragment detachment during use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 29, 2026device recall195d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Single Use Biopsy Valve. Model/Catalog Number: MAJ-1218. 20 units per box. The MAJ-1218 has been designed to be attached to the instrument channel port of compatible endoscopes to prevent leakage of body fluids. — Reason: Potential for rubber fragment detachment during use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 29, 2026device recall195d agoReCor Medical Inc. device recall (Cls II)VYCOR MEDICAL INC

    Brand Name: Paradise¿ Ultrasound Renal Denervation System Product Name: Paradise ¿ Catheter Model/Catalog Number: PRDS-068-02 Product Description: Common name: Ablation catheter renal denervation — Reason: Due to firm distributing a nonconforming product that supposed to be scrapped and not for human use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 29, 2026device recall195d agoReCor Medical Inc. device recall (Cls II)VYCOR MEDICAL INC

    Brand Name: Paradise¿ Ultrasound Renal Denervation System Product Name: Paradise ¿ Catheter Model/Catalog Number: PRDS-068-02 Product Description: Common name: Ablation catheter renal denervation — Reason: Due to firm distributing a nonconforming product that supposed to be scrapped and not for human use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 29, 2026grant195d agoUNIVERSITY OF PENNSYLVANIA — Organizational Changes to Reduce Nurse BurnoutUniversity of Pennsylvania

    NR grant. $2,009,207. PI: Karen Blanchette Lasater

    full page →nih reporter ↗
    ›Jan 29, 2026grant195d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — The role of CD69 in established resident memory T cellsNew York University

    AI grant. $466,125. PI: Susan Ruth Schwab

    full page →nih reporter ↗
    ›Jan 29, 2026grant195d agoUNIVERSITY OF NEBRASKA MEDICAL CENTER — Interplay Between Transcription and ATP-dependent Chromatin Remodeling for Ge...

    GM grant. $280,905. PI: Sandipan Brahma

    full page →nih reporter ↗
    ›Jan 30, 2026approval194d agoZYPREXA ZYDIS (OLANZAPINE) — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoBRIVARACETAM — FDA approvalUCB SA

    Sponsor: SUNSHINE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoBRIVARACETAM — FDA approvalUCB SA

    Sponsor: SUNSHINE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoZYPREXA RELPREVV (OLANZAPINE PAMOATE) — FDA approvalCHEPLAPHARM Arzneimittel GmbH

    Sponsor: CHEPLAPHARM. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Jan 30, 2026approval194d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoARSENIC TRIOXIDE — FDA approvalQuetzal Therapeutics LLC

    Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoEPIRUBICIN HYDROCHLORIDE — FDA approvalEPIRUBICIN HYDROCHLORIDE

    Sponsor: CIPLA LTD. Form: INJECTABLE. Route: INJECTION

    full page →EPIRUBICIN HYDROCHLORIDE →fda approvals ↗
    ›Jan 30, 2026approval194d agoAMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approvalHikma Pharmaceuticals Plc

    Sponsor: HIKMA PHARMS. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: PH HEALTH. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoLIVDELZI (SELADELPAR LYSINE) — FDA approvalseladelpar lysine

    Sponsor: GILEAD SCIENCES INC. Form: CAPSULE. Route: ORAL

    full page →seladelpar lysine →fda approvals ↗
    ›Jan 30, 2026approval194d agoLATANOPROST — FDA approvalXalatan

    Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Xalatan →fda approvals ↗
    ›Jan 30, 2026approval194d agoLATANOPROST — FDA approvalXalatan

    Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Xalatan →fda approvals ↗
    ›Jan 30, 2026approval194d agoLATANOPROST — FDA approvalXalatan

    Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Xalatan →fda approvals ↗
    ›Jan 30, 2026approval194d agoEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE (EMTRICITABINE) — FDA approvalemtricitabine

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →emtricitabine →fda approvals ↗
    ›Jan 30, 2026approval194d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 30, 2026approval194d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 30, 2026approval194d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 30, 2026approval194d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 30, 2026approval194d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 30, 2026approval194d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoLYBALVI (OLANZAPINE) — FDA approval(olanzapine + samidorphan l-malate)

    Sponsor: ALKERMES INC. Form: TABLET. Route: ORAL

    full page →(olanzapine + samidorphan l-malate) →fda approvals ↗
    ›Jan 30, 2026approval194d agoVENLAFAXINE HYDROCHLORIDE — FDA approvalViatris Inc

    Sponsor: PLATINUM. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoCETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE) — FDA approvalCETIRIZINE HYDROCHLORIDE

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →CETIRIZINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 30, 2026approval194d agoDAPTOMYCIN — FDA approvalDaptomycin Novo

    Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS

    full page →Daptomycin Novo →fda approvals ↗
    ›Jan 30, 2026approval194d agoOZEMPIC (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

    Sponsor: NOVO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoENBREL (ETANERCEPT) — FDA approvalAMGEN INC

    Sponsor: IMMUNEX. Form: SYRINGE

    full page →fda approvals ↗
    ›Jan 30, 2026approval194d agoVALACYCLOVIR HYDROCHLORIDE — FDA approvalVALACYCLOVIR HYDROCHLORIDE

    Sponsor: JUBILANT GENERICS. Form: TABLET. Route: ORAL

    full page →VALACYCLOVIR HYDROCHLORIDE →fda approvals ↗
    ›Jan 30, 2026device 510k194d agoHangzhou Clongene Biotech Co., Ltd. — Clungene RSV Antigen Rapid Test (510k cleared)Hangzhou DAC Biotech Co Ltd

    Product code: GQG. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 30, 2026device 510k194d agoShenzhen Peninsula Medical Group — ZenTite (Unicorn+); ZenTite (Unicorn+I); ZenTite (Unicorn+II); ZenTite (Unicorn+III) (510k cleared)

    Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Special

    full page →fda device 510k ↗
    ›Jan 30, 2026device 510k194d agoSaeshin Precision Co., Ltd. — Motor Handpiece and Control Unit (SDI10) (510k cleared)

    Product code: EBW. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ← prev
    page 7 of 192
    next →
    $RDY12.45+2.47%
    $NEO14.73+3.44%
    $VYCO0.06600.00%
    $CNMD32.58+1.46%
    $GILD135.77+2.04%
    $TEVA36.48+0.94%
    $FMS23.87-1.97%
    $CODX1.51000.00%
    $TEVA36.48+0.94%
    $VYCO0.06600.00%
    $ALKS49.21-0.38%
    $AMGN414.30-0.70%
    $VTRS16.280.00%